Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P7YR | ISIN: US86887Q1094 | Ticker-Symbol: 0GV
Frankfurt
03.05.24
08:05 Uhr
3,540 Euro
+0,080
+2,31 %
1-Jahres-Chart
SURO CAPITAL CORP Chart 1 Jahr
5-Tage-Chart
SURO CAPITAL CORP 5-Tage-Chart
RealtimeGeldBriefZeit
3,4403,56004.05.
3,5003,54003.05.

Aktuelle News zur SURO CAPITAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoSuRo Capital Corp. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 20241
16.04.SuRo Capital Corp. First Quarter 2024 Preliminary Investment Portfolio Update79NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. ("SuRo Capital", the "Company", "we", "us", and "our") (Nasdaq: SSSS) today provided the following preliminary update on its investment...
► Artikel lesen
16.04.SURO CAPITAL CORP. - 8-K, Current Report1
03.04.SuRo Capital announces expiration and final results of Tender Offer3
22.03.SURO CAPITAL CORP. - 8-K, Current Report1
22.03.SuRo Capital Corp. Tender Offer Expiring on April 1, 2024 at 5:00 P.M., Eastern Time4
15.03.Earnings call: SuRo Capital reports Q4 results amid private market slump2
14.03.SURO CAPITAL CORP. - 10-K, Annual Report1
13.03.Recap: SuRo Capital Q4 Earnings1
13.03.SuRo Capital reports Q4 results1
13.03.SuRo Capital Corp. Reports Fourth Quarter and Fiscal Year 2023 Financial Results34Net Asset Value of $7.99 Per Share as of December 31, 2023 Modified Dutch Auction Tender Offer to Repurchase Up To 2 Million Shares Commenced on February 20 NEW YORK, March 13...
► Artikel lesen
13.03.SURO CAPITAL CORP. - 8-K, Current Report1
12.03.Earnings Outlook For SuRo Capital3
06.03.SuRo Capital Corp. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on Wednesday, March 13, 20241
15.02.Manulife Financial, SuRo Capital among financials gainers; B. Riley in losers7
16.01.SuRo Capital trims NAV range estimate in Q4 vs. Q36
16.01.SuRo Capital Corp. Fourth Quarter and Fiscal Year 2023 Preliminary Investment Portfolio Update213NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. ("SuRo Capital", the "Company", "we", "us", and "our") (Nasdaq: SSSS) today provided the following preliminary update on its investment...
► Artikel lesen
16.01.SURO CAPITAL CORP. - 8-K, Current Report2
29.11.23SURO CAPITAL CORP. - 8-K, Current Report3
15.11.23Biostax Corp: Biostax Announces a Director Appointment of Influential Business Leader Craig Suro2
Seite:  Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1